← All trials
NCT05146089
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 20, 2016
- Primary completion
- Sep 8, 2018
- Completion date
- Apr 12, 2021
- First posted
- Dec 6, 2021
- Last posted
- Dec 6, 2021
- Enrollment
- 54
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of MissouriLead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- Mayo ClinicCollaborator
- University of MissouriReponsible party - principal investigator
- University of MissouriOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.